Optimizing treatment of chronic myeloid leukemia: a rational approach.
about
Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias after imatinib resistance or intoleranceTrough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia.Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemiaDasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia.Chronic Myeloid Leukaemia in The 21st Century.Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1.Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients.How long will chronic myeloid leukemia patients treated with imatinib mesylate live?Impact of tailored patient education on adherence of patients with chronic myeloid leukaemia to tyrosine kinase inhibitors: a randomized multicentre intervention study.Lack of congruence between patients' and health professionals' perspectives of adherence to imatinib therapy in treatment of chronic myeloid leukemia: A qualitative study
P2860
Q33388870-A725DFC5-9EF9-4874-9C65-24DB3542F6F1Q33394772-EE0E7837-D742-4528-A19E-56F25165E70EQ35848663-BBDDACF6-2C2F-4881-9CFE-AFABFC0AFAA4Q35876347-A2782EF3-9113-4CC0-8685-DFB05016A932Q36731265-AE70B66F-B4C0-4A38-B57B-739239421031Q37183838-9AB3987A-614C-469C-8BA8-9561DD9C41F2Q38475230-18B84AB5-66FD-4608-B1E6-21F70D8AC5E2Q46463385-65AE5F8C-759F-411F-94A4-BC18D3EC2760Q55025022-D4265EF8-3F2A-42DF-B903-D2DC11C6E6B0Q57143102-1C1EA0EF-93F2-435E-8422-F0FF4176676C
P2860
Optimizing treatment of chronic myeloid leukemia: a rational approach.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Optimizing treatment of chronic myeloid leukemia: a rational approach.
@ast
Optimizing treatment of chronic myeloid leukemia: a rational approach.
@en
type
label
Optimizing treatment of chronic myeloid leukemia: a rational approach.
@ast
Optimizing treatment of chronic myeloid leukemia: a rational approach.
@en
prefLabel
Optimizing treatment of chronic myeloid leukemia: a rational approach.
@ast
Optimizing treatment of chronic myeloid leukemia: a rational approach.
@en
P1433
P1476
Optimizing treatment of chronic myeloid leukemia: a rational approach.
@en
P2093
Richard M Stone
P304
P356
10.1634/THEONCOLOGIST.9-3-259
P577
2004-01-01T00:00:00Z